SB20-107
Drug Production Costs Transparency Analysis Report
Concerning an analysis of prescription drug manufacturer data on high-cost prescription drugs paid for by specified state departments to determine the components of the production process that drive the price of the prescription drugs.
06/3/2020 | Senate Second Reading Laid Over to 12/31/2020 - No Amendments
2020 Regular Session
Bill
Health Care & Health Insurance
State Government